Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The Fong lab is seeking an experienced Research Technician I or Research Technician II to work in a collaborative environment leading research on cancer immunotherapy. The focus of our lab is to unravel the mechanisms of response and resistance to cancer immunotherapy. In addition, candidates with significant expertise in antibody-medicated cell enrichment procedures, flow cytometry, and cell cryopreservation will be viewed as highly favorable candidates.
This is expected to be a long-term position and the successful applicant will help oversee the day to day running of the mouse colony in collaboration with senior graduate laboratory members. The candidate will also contribute to multiple projects studying the dynamic interactions governing the generation of anti-tumor immunity and apply this knowledge toward developing novel approaches for the study and treatment of cancer. The technician will be closely involved in research projects using in vivo murine models of transplantation, cancer patient-derived samples, and engineered cell therapy models combined with single cell, spatial, and computational approaches to study the dynamics of an immune response.
The successful applicant will ideally have a basic knowledge of immunology and colony management with previous experience in laboratory murine handling, genotyping, and cell culture, and be capable of maintaining detailed laboratory records.
In conjunction with the senior Research Technicians, key duties will include:
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Research Technician I: The hourly pay range for this position is from $22.21 to $31.61 and pay offered will be based on experience and qualifications.
Research Technician II: The hourly pay range for this position is from $25.71 to $36.60 and pay offered will be based on experience and qualifications.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (12-22 days per year), paid sick leave (12-25 days per year), paid holidays (13 days per year), paid parental leave (up to 4 weeks), and partially paid sabbatical leave (up to 6 months).
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide.
An independent, nonprofit organization, Fred Hutch also serves as UW Medicine’s cancer program. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Fred Hutchinson Cancer Center will accelerate the development, evaluation, and use of new cancer discoveries and treatments and will offer patients greater access to clinical trials, bringing research and clinical care closer together. For current patients the superior care you have come to expect from us will continue uninterrupted. For example, as part of the transition to Fred Hutch there will be no changes to your doctor or care team. Over the longer term, this update to our structure will enable us to improve patients’ care experiences and increase integration across your care team.
Fred Hutch will focus on integrating teams and operations over the coming weeks and months but you will see some new changes coming soon.
During the transition and afterward, high-quality patient care, research and operations will continue uninterrupted. Seattle Children's, an original SCCA alliance partner, will work in close partnership with Fred Hutchinson Cancer Center to advance breakthroughs in adult and pediatric oncology.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Learn more about UW Medicine
Learn more about our research at Fred Hutch